HOME
CAREERS
CONTACT US
KOREAN
ENGLISH
KR
EN
Toggle navigation
COMPANY
ABOUT US
KEY MEMBERS
HISTORY
BOARD OF DIRECTORS
SCIENTIFIC ADVISORY BOARD
SCIENCE
NT-I7
NeoBase
NT2020
NT3020
NT4010
NT5010
PIPELINE
Clinical
R&D
COLLABORATION
INVESTORS
NOTICE
PRESENTATION
GENERAL MEETING
OF STOCKHOLDERS
INDEPENDENT
AUDITOR'S REPORT
CONTACT IR
MEDIA
NEWS
VIDEO SOURCE
ESG
OVERVIEW
ENVIRONMENTAL
SOCIAL
GOVERNANCE
NeoImmuneTech is
Expanding the Horizon of Immuno-Oncology and
Enhancing Immunity to Infectious Diseases
Learn more about our company
NT-I7
, Our Lead Drug Candidate, is
a Unique T Cell Amplifier
Learn more about our science
Advancing Clinical Development
in Oncology and Immunology
Learn more about our clinical trials